Total Payments
$24,570
2024 Payments
$1,347
Companies
35
Transactions
671
Medicare Patients
10,180
Medicare Billing
$2.6M
Payment Breakdown by Category
Other$12,770 (52.0%)
Food & Beverage$11,226 (45.7%)
Education$549.22 (2.2%)
Travel$25.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,226 | 639 | 45.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,270 | 6 | 33.7% |
| Honoraria | $4,500 | 3 | 18.3% |
| Education | $549.22 | 22 | 2.2% |
| Travel and Lodging | $25.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $5,489 | 24 | $0 (2019) |
| The Medicines Company | $5,193 | 44 | $0 (2018) |
| Merck Sharp & Dohme LLC | $3,157 | 72 | $0 (2024) |
| ViiV Healthcare Company | $2,785 | 184 | $0 (2024) |
| Melinta Therapeutics, LLC | $1,928 | 28 | $0 (2020) |
| Gilead Sciences, Inc. | $1,617 | 100 | $0 (2024) |
| Janssen Biotech, Inc. | $895.95 | 55 | $0 (2023) |
| Smith+Nephew, Inc. | $661.11 | 53 | $0 (2024) |
| Insmed, Inc. | $588.02 | 25 | $0 (2024) |
| Theratechnologies Inc. | $334.26 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,347 | 75 | ViiV Healthcare Company ($602.97) |
| 2023 | $1,179 | 75 | ViiV Healthcare Company ($381.57) |
| 2022 | $1,086 | 60 | ViiV Healthcare Company ($399.92) |
| 2021 | $1,604 | 75 | ViiV Healthcare Company ($391.35) |
| 2020 | $1,453 | 76 | ViiV Healthcare Company ($401.28) |
| 2019 | $3,455 | 108 | Merck Sharp & Dohme Corporation ($2,138) |
| 2018 | $5,083 | 97 | Allergan Inc. ($2,147) |
| 2017 | $9,362 | 105 | The Medicines Company ($5,180) |
All Payment Transactions
671 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $53.10 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: HIV | ||||||
| 12/06/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: HIV | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.10 | General |
| 12/03/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/14/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: HIV | ||||||
| 11/12/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: HIV | ||||||
| 11/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.60 | General |
| 11/01/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: HIV | ||||||
| 10/29/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/28/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: HIV | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: HIV | ||||||
| 09/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: HIV | ||||||
| 09/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.52 | General |
| 09/17/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: HIV | ||||||
| 09/17/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: HIV | ||||||
| 09/10/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: HIV | ||||||
| 09/10/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Infections and Infectious Diseases | ||||||
| 08/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: HIV | ||||||
| 08/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: HIV | ||||||
| 08/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: HIV | ||||||
| 08/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,538 | 594,851 | $4.1M | $557,114 |
| 2022 | 21 | 2,515 | 505,031 | $3.4M | $558,813 |
| 2021 | 21 | 2,566 | 736,325 | $4.1M | $698,479 |
| 2020 | 22 | 2,561 | 782,169 | $4.2M | $767,252 |
Total Patients
10,180
Total Services
2,618,376
Medicare Billing
$2.6M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 100 | 2,786 | $585,060 | $138,323 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 497 | 1,653 | $234,313 | $105,719 | 45.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 446 | 519 | $141,168 | $55,071 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 535 | $110,745 | $52,271 | 47.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 255 | 530 | $107,590 | $51,226 | 47.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 186 | 205 | $81,590 | $28,929 | 35.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 45 | 1,269 | $251,262 | $28,451 | 11.3% |
| J0878 | Injection, daptomycin, 1 mg | Office | 2023 | 46 | 570,200 | $1.1M | $23,911 | 2.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $31,654 | $12,845 | 40.6% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 23 | 634 | $123,630 | $10,157 | 8.2% |
| J1335 | Injection, ertapenem sodium, 500 mg | Office | 2023 | 13 | 740 | $67,700 | $7,904 | 11.7% |
| J0692 | Injection, cefepime hydrochloride, 500 mg | Office | 2023 | 47 | 6,708 | $575,400 | $6,602 | 1.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 80 | $16,560 | $6,295 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 41 | $11,398 | $5,268 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 77 | $10,703 | $5,230 | 48.9% |
| J3370 | Injection, vancomycin hcl, 500 mg | Office | 2023 | 25 | 1,935 | $240,270 | $3,512 | 1.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 95 | 466 | $2,796 | $2,740 | 98.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,510 | $2,702 | 41.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 100 | 5,020 | $210,840 | $2,544 | 1.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 55 | 58 | $10,208 | $2,393 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 33 | $4,587 | $1,760 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 38 | $3,154 | $1,662 | 52.7% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 19 | 23 | $5,520 | $1,117 | 20.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 1,172 | $99,704 | $483.06 | 0.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 99 | 2,627 | $551,670 | $138,709 | 25.1% |
About Dr. Ivan Soosaipillai, MD
Dr. Ivan Soosaipillai, MD is a Internal Medicine healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649289059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Soosaipillai, MD has received a total of $24,570 in payments from pharmaceutical and medical device companies, with $1,347 received in 2024. These payments were reported across 671 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($11,226).
As a Medicare-enrolled provider, Soosaipillai has provided services to 10,180 Medicare beneficiaries, totaling 2,618,376 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Ocala, FL
- Active Since 08/05/2006
- Last Updated 07/07/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649289059
Products in Payments
- ORBACTIV (Drug) $4,817
- TEFLARO (Drug) $3,217
- DIFICID (Drug) $2,181
- DALVANCE (Drug) $2,174
- Vabomere (Drug) $1,583
- DOVATO (Drug) $1,395
- Arikayce (Drug) $566.74
- SYMTUZA (Drug) $534.09
- CABENUVA (Biological) $497.12
- ZERBAXA (Drug) $484.62
- Santyl (Drug) $431.03
- RUKOBIA (Drug) $362.93
- MINOCIN IV (Drug) $321.69
- EGRIFTA (Drug) $275.28
- Fetroja (Drug) $223.76
- Baxdela (Drug) $209.29
- Symtuza (Drug) $206.31
- JULUCA (Drug) $202.63
- COLLAGENASE SANTYL (Drug) $202.62
- TRIUMEQ (Drug) $173.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ocala
Anil Gogineni, M.d, M.D
Internal Medicine — Payments: $174,038
Internal Medicine $174,038
Dr. Jayanti Panchal, M.d, M.D
Internal Medicine — Payments: $117,864
Internal Medicine $117,864
Dr. Andrew Seevaratnam, M.d, M.D
Internal Medicine — Payments: $46,620
Internal Medicine $46,620
Dr. Jose Roman, Md, MD
Internal Medicine — Payments: $31,511
Internal Medicine $31,511
Premranjan Singh, Md, MD
Internal Medicine — Payments: $29,195
Internal Medicine $29,195
Dr. Mohamed Suliman, Md, MD
Internal Medicine — Payments: $24,006
Internal Medicine $24,006